豚草花粉過敏治療市場：按藥物類別、通路和地區分類

Ragweed Pollen Allergy Treatment Market, by Drug Class, by Distribution Channel, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，豚草花粉過敏治療市場價值將達到 10.95 億美元，到 2033 年將達到 15.203 億美元。預計從 2026 年到 2033 年，該市場將以 4.8% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	10.95億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.80%	2033年市場規模預測：	15.203億美元

豚草是豚草過敏患者的過敏原。豚草花粉由漂浮在空氣中的細小顆粒組成，會引起豚草過敏患者的過敏症狀。豚草過敏的常見症狀包括咳嗽、流鼻水和喉嚨發癢。豚草花粉是一種粉狀物質，由細小的顆粒（即花粉粒）組成。這些花粉粒有助於其他豚草植物授粉。一株豚草植物可產生多達10億粒花粉，這些花粉粒漂浮在空氣中，要麼結成種子，要麼進入鼻子、眼睛和嘴巴，給過敏患者帶來極大的不適。花粉也會附著在衣服、頭髮和皮膚上。與其他花粉過敏一樣，豚草過敏會導致季節性過敏性鼻炎（花粉症）和鼻腔發炎。對豚草過敏的人來說，接觸豚草或吸入空氣中的豚草顆粒都可能引起豚草疹子。其他常見的豚草過敏症狀包括鼻塞、流鼻水、鼻後滴漏、打噴嚏、咳嗽、眼睛發紅、發癢和刺激、眼睛腫脹（「過敏性眼腫」）、疲勞和蕁麻疹。接觸豚草花粉的人可能會在接觸後24至48小時內注意到皮膚上發癢的紅色條紋。這種皮疹可能會疼痛，並可能形成水痘。豚草皮疹永續2至3週，但通常會自行消退。豚草花粉會加重氣喘症狀。如果同時患有氣喘和豚草過敏的人吸入豚草花粉，可能會引起肺部和氣道發炎和腫脹。過敏性氣喘患者需要治療氣喘症狀，但他們可能也需要治療過敏本身。

市場動態

預計主要市場參與者不斷推出新產品以及併購將推動全球豚草花粉過敏治療市場的成長。例如，2021年4月19日，專注於研發和生產用於預防和治療過敏的過敏免疫療法（AIT）產品的丹麥製藥公司ALK宣布，美國食品藥物管理局（FDA）已批准其RAGWITEK（短豚草花粉過敏原提取物）舌下片用於治療5至65歲患者的短豚草花粉發炎。 RAGWITEK是一種過敏原萃取物，適用於治療經皮膚試驗或體外短豚草花粉試驗確診為陽性的短豚草花粉誘發的過敏性鼻炎，無論是否伴隨結膜炎。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了全球豚草花粉過敏治療市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球豚草花粉過敏治療市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用各種策略矩陣來分析全球豚草花粉過敏治療市場，從而簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

ALK-Abello A/S
ASIT Biotech SA
Anergis SA
Biomay AG
Astellas Pharma Inc.
Thermo Fisher Scientific Inc
Siemens Healthcare Private Limited
Omega Diagnostics Group PLC
Stallergenes Greer
bioMerieux SA
Lincoln Diagnostics, Inc.
HOB Biotech Group Corp Ltd
HYCOR Biomedical Inc.
Alcon
Hitachi Chemical Diagnostics Inc.
Quest Diagnostics Incorporated
Circassia
Immunomic Therapeutics Inc.
Novartis AG
Japan Tobacco Inc
GlaxoSmithKline plc
REGiMMUNE Co, Ltd
Sanofi
Merck KGaA

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI4054

Ragweed Pollen Allergy Treatment Market is estimated to be valued at USD 1,095.0 Mn in 2026 and is expected to reach USD 1,520.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,095.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.80%	2033 Value Projection:	USD 1,520.3 Mn

Ragweed is an allergen for people allergic to ragweed. Ragweed pollen is made of tiny particles that float through the air and cause allergy symptoms in people who are allergic to ragweed. Of all ragweed allergy symptoms, cough, runny nose, and an itchy throat are the most common. Ragweed pollen is a powdery substance that consists of tiny particles, or grains. The grains of pollen help fertilize other ragweed plants. One ragweed plant can produce up to 1 billion pollen grains that can float through the air, and either produce seeds or end up in the nose, eyes or mouth, causing great discomfort if a person is allergic to it. Pollen can also collect on clothes, hair, and the skin. Like all pollen allergies, allergies to ragweed can lead to seasonal allergic rhinitis (hay fever), inflammation of the nasal passages. For people with a ragweed allergy, exposure to the plant by touch or through airborne particles can lead to them developing a ragweed rash. Other common ragweed allergy symptoms are: nasal congestion, runny nose with thin, water discharge, postnasal drip, sneezing, coughing, watery, itchy or irritated eyes, eye swelling- the "allergic shiner", weakness or fatigue, hives on the skin. A person who has been exposed to ragweed pollen may notice itchy red streaks appearing on his skin 24 to 48 hours after exposure. The rash can be painful and may form into blisters. Ragweed rash can last anywhere from two to three weeks and will usually improve on its own. Ragweed pollen can cause asthma symptoms to flare up. When a person with asthma and ragweed allergy inhales ragweed pollen, it can cause the lungs and airways to become inflamed and swollen. People with allergic asthma will require treatment for its asthma symptoms, but they may also require treatment for its allergies.

Market Dynamics

Increasing launches of new products, and mergers and acquisitions by key market players is expected to drive the global ragweed pollen allergy treatment market growth. For instance, on April 19, 2021, ALK, a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy, announced that the U.S. Food and Drug Administration (FDA) approved RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the treatment of short ragweed pollen-induced allergic rhinitis in persons ages five through 65. RAGWITEK is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ragweed pollen allergy treatment market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include ALK-Abello A/S, ASIT Biotech SA, Anergis SA, Biomay AG, and Astellas Pharma Inc., Thermo Fisher Scientific Inc, Siemens Healthcare Private Limited, Omega Diagnostics Group PLC, Stallergenes Greer, bioMerieux SA, Lincoln Diagnostics, Inc, HOB Biotech Group Corp Ltd, HYCOR Biomedical, Inc, Alcon, Hitachi Chemical Diagnostics, Inc, Quest Diagnostics Incorporated, Circassia, Immunomic Therapeutics, Inc, Novartis AG, Japan Tobacco Inc, GlaxoSmithKline plc, REGiMMUNE Co, Ltd, Sanofi, and Merck KGaA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global ragweed pollen allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ragweed pollen allergy treatment market

Detailed Segmentation:

Global Ragweed Pollen Allergy Treatment Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)
Antihistamines
Decongestants
Nasal Corticosteroids
Others
Global Ragweed Pollen Allergy Treatment Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospital Pharmacy
Retail Pharmacy
Online Channel
Global Ragweed Pollen Allergy Treatment Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
ALK-Abello A/S
ASIT Biotech SA
Anergis SA
Biomay AG
Astellas Pharma Inc.
Thermo Fisher Scientific Inc
Siemens Healthcare Private Limited
Omega Diagnostics Group PLC
Stallergenes Greer
bioMerieux SA
Lincoln Diagnostics, Inc
HOB Biotech Group Corp Ltd
HYCOR Biomedical, Inc
Alcon
Hitachi Chemical Diagnostics, Inc
Quest Diagnostics Incorporated
Circassia
Immunomic Therapeutics, Inc
Novartis AG
Japan Tobacco Inc
GlaxoSmithKline plc
REGiMMUNE Co, Ltd
Sanofi
Merck KGaA.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Ragweed Pollen Allergy Treatment Market, By Drug Class, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Nasal Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

5. Global Ragweed Pollen Allergy Treatment Market, By Distribution Channel, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
Online Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)

6. Global Ragweed Pollen Allergy Treatment Market, By Region, 2021-2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

ALK-Abello A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ASIT Biotech SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Anergis SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Biomay AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Siemens Healthcare Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Omega Diagnostics Group PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Stallergenes Greer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lincoln Diagnostics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
HOB Biotech Group Corp Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
HYCOR Biomedical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Alcon
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Hitachi Chemical Diagnostics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Circassia
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Immunomic Therapeutics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Japan Tobacco Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
REGiMMUNE Co, Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies